10x Genomics annual depreciation and amortization
2017
2018
2019
2020
2021
2022
2023
2024
2025
10x Genomics Depreciation & Amortization Growth & History (TXG)
10x Genomics's depreciation and amortization was $36.2M for fiscal 2025.
View full 10x Genomics company overview10x Genomics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $36.2M | $320,000 | +0.89% |
| 2024 | 2024-12-31 | $35.9M | $367,000 | +1.03% |
| 2023 | 2023-12-31 | $35.5M | $10.1M | +39.99% |
| 2022 | 2022-12-31 | $25.4M | $4.3M | +20.13% |
| 2021 | 2021-12-31 | $21.1M | $7.1M | +50.71% |
| 2020 | 2020-12-31 | $14.0M | $6.9M | +98.30% |
| 2019 | 2019-12-31 | $7.1M | $3.2M | +80.95% |
| 2018 | 2018-12-31 | $3.9M | −$400,000 | −9.29% |
| 2017 | 2017-12-31 | $4.3M | — | — |
10x Genomics quarterly depreciation and amortization
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $9.7M | $1.8M | +23.66% |
| Q1 2026 | 2026-03-31 | $10.0M | $1.9M | +24.12% |
| Q4 2025 | 2025-12-31 | $12.1M | — | — |
| Q3 2025 | 2025-09-30 | $10.3M | $1.3M | +14.87% |
| Q2 2025 | 2025-06-30 | $7.8M | −$1.2M | −12.89% |
| Q1 2025 | 2025-03-31 | $8.0M | −$1.2M | −12.75% |
| Q3 2024 | 2024-09-30 | $9.0M | −$408,000 | −4.35% |
| Q2 2024 | 2024-06-30 | $9.0M | −$970,000 | −9.76% |
| Q1 2024 | 2024-03-31 | $9.2M | $2.7M | +41.84% |
| Q3 2023 | 2023-09-30 | $9.4M | $3.2M | +52.24% |
| Q2 2023 | 2023-06-30 | $9.9M | $3.4M | +52.94% |
| Q1 2023 | 2023-03-31 | $6.5M | $291,000 | +4.70% |
| Q3 2022 | 2022-09-30 | $6.2M | $460,000 | +8.08% |
| Q2 2022 | 2022-06-30 | $6.5M | $1.6M | +32.95% |
| Q1 2022 | 2022-03-31 | $6.2M | $1.4M | +30.28% |
| Q3 2021 | 2021-09-30 | $5.7M | $2.1M | +58.57% |
| Q2 2021 | 2021-06-30 | $4.9M | $1.6M | +47.57% |
| Q1 2021 | 2021-03-31 | $4.8M | $1.6M | +49.01% |
| Q3 2020 | 2020-09-30 | $3.6M | $1.6M | +75.99% |
| Q2 2020 | 2020-06-30 | $3.3M | $2.2M | +189.60% |
| Q1 2020 | 2020-03-31 | $3.2M | $2.2M | +207.82% |
| Q3 2019 | 2019-09-30 | $2.0M | — | — |
| Q2 2019 | 2019-06-30 | $1.1M | — | — |
| Q1 2019 | 2019-03-31 | $1.0M | — | — |
10x Genomics depreciation and amortization trends
Over the last five fiscal years, 10x Genomics's depreciation and amortization increased from $14.0M to $36.2M, a change of $22.2M. The latest reported quarter, Q2 2026, shows $9.7M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review 10x Genomics source filings ↗